(ARGX) Argen-X - Performance 14.3% in 12m
ARGX performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
66.57%
#4 in Peer-Group
Rel. Strength
59.86%
#3081 in Stock-Universe
Total Return 12m
14.33%
#55 in Peer-Group
Total Return 5y
118.61%
#10 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | 33.6 |
| P/E Forward | 55.0 |
| High / Low | EUR |
|---|---|
| 52 Week High | 653.60 EUR |
| 52 Week Low | 423.40 EUR |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 14.31 |
| Buy/Sell Signal +-5 | 0.95 |
| Support / Resistance | Levels |
|---|---|
| Support | |
| Resistance |
12m Total Return: ARGX (14.3%) vs XBI (-7%)
5y Drawdown (Underwater) Chart
Top Performer in Biotechnology
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| GILD NASDAQ Gilead Sciences |
3.23% | 73% | 77.8% | 22.7 | 13.6 | 0.23 | 28.3% | -3.71% |
| UTHR NASDAQ United Therapeutics |
-9.1% | -6.38% | 147% | 11.3 | 10.5 | 1.43 | 74.6% | 16.1% |
| AMGN NASDAQ Amgen |
3.91% | -0.97% | 36% | 25.4 | 13.4 | 0.93 | 0.60% | 41% |
| BIM PA Biomerieux |
1.34% | 27.6% | -4.82% | 33.1 | 25.8 | 1.55 | -38.5% | -25.1% |
| NBIX NASDAQ Neurocrine Biosciences |
3.69% | -7.17% | 1.14% | 43 | 24.8 | 0.27 | 18.7% | -34.3% |
| KMDA NASDAQ Kamada |
18.3% | 43% | -4.19% | 27.6 | 22.4 | 0.9 | 68.9% | 36.8% |
| PTCT NASDAQ PTC Therapeutics |
-4.03% | 58.7% | -9.25% | 7.71 | 6.26 | 0.81 | - | 68% |
| ERF PA Eurofins Scientific SE |
6.2% | 28.7% | 15.2% | 28.9 | 15.4 | 0.64 | -62.1% | -19.3% |
Performance Comparison: ARGX vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for ARGX
| Total Return (including Dividends) | ARGX | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | -9.37% | 3.36% | 5.25% |
| 3 Months | -11.53% | 15.73% | 24.13% |
| 12 Months | 14.33% | -7.02% | 14.15% |
| 5 Years | 118.61% | -24.21% | 111.83% |
| Trend Score (consistency of price movement) | ARGX | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | -78.4% | 4.4% | 81% |
| 3 Months | -65.8% | 78.8% | 96.9% |
| 12 Months | 32% | -85.8% | 44.9% |
| 5 Years | 90.6% | -52.6% | 84% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
|---|---|---|---|
| 1 Month | %th27.00 | -12.31% | -13.89% |
| 3 Month | %th18.50 | -23.55% | -28.73% |
| 12 Month | %th73.50 | 22.97% | 0.15% |
| 5 Years | %th96.50 | 188.45% | 3.20% |
FAQs
Does Argen-X (ARGX) outperform the market?
Yes,
over the last 12 months ARGX made 14.33%, while its related Sector, the SPDR S&P Biotech (XBI) made -7.02%.
Over the last 3 months ARGX made -11.53%, while XBI made 15.73%.
Performance Comparison ARGX vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
ARGX vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | -5.6% | -14.6% | -30.1% | 0% |
| US NASDAQ 100 | QQQ | -5.4% | -14.7% | -30.8% | 2% |
| German DAX 40 | DAX | -3.5% | -8% | -42.3% | -15% |
| Shanghai Shenzhen CSI 300 | CSI 300 | -5.5% | -12.6% | -33.6% | -6% |
| Hongkong Hang Seng | HSI | -5.3% | -15.4% | -49.6% | -24% |
| India NIFTY 50 | INDA | -3.8% | -12.8% | -30.5% | 15% |
| Brasil Bovespa | EWZ | -8.1% | -18.2% | -55.2% | 4% |
ARGX vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | -4.3% | -15.3% | -34.3% | -10% |
| Consumer Discretionary | XLY | -5.1% | -12.5% | -22.5% | -4% |
| Consumer Staples | XLP | -6% | -10% | -31.8% | 5% |
| Energy | XLE | -6% | -16.4% | -26% | 15% |
| Financial | XLF | -6.4% | -14.5% | -35.1% | -16% |
| Health Care | XLV | -5.1% | -11.5% | -22.8% | 19% |
| Industrial | XLI | -5.7% | -13.6% | -38% | -11% |
| Materials | XLB | -7.9% | -13.7% | -34.7% | 8% |
| Real Estate | XLRE | -5.6% | -10.4% | -29.9% | 2% |
| Technology | XLK | -6.4% | -18.1% | -32.5% | 3% |
| Utilities | XLU | -4.6% | -11.2% | -33.4% | -9% |
| Aerospace & Defense | XAR | -3.5% | -16.4% | -48.7% | -35% |
| Biotech | XBI | -6.6% | -12.7% | -16.9% | 21% |
| Homebuilder | XHB | -8.1% | -16.4% | -23% | 9% |
| Retail | XRT | -8.2% | -14.4% | -25.8% | 3% |
ARGX vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | -6.6% | -17.8% | -21.8% | 22% |
| Natural Gas | UNG | 3.9% | 0.5% | -13.4% | 17% |
| Gold | GLD | -5.9% | -8.2% | -50.8% | -25% |
| Silver | SLV | -6.7% | -16.3% | -47.5% | -3% |
| Copper | CPER | -4.7% | -14% | -47.2% | 3% |
ARGX vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | -3.8% | -10.4% | -26.7% | 16% |
| iShares High Yield Corp. Bond | HYG | -4.5% | -11% | -29% | 4% |